Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Xuening Wang
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Anatomy
Chemicals & Drugs
Physiology
Phenomena
Concepts & Ideas
Procedures
Sign-in to see full Profile
Network (preview)
23
Studzinski, George
3
Wang, Qing
3
Garay, Edward
2
Gocek, Elzbieta
2
Dutz, Jan
2
Tan, Rusung
2
Harrison, Jonathan
2
Ji, Yan
1
Junker, Anne
1
Kutner, Andrzej
1
Marcinkowska, Ewa
1
Mori, Kazuyasu
1
Onlamoon, Nattawat
1
Pattanapanyasat, Kovit
1
Pereira, Lara
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Xuening Wang (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Wang Xuening; Gocek Elzbieta; Liu Chang-Gong; Studzinski George P
MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3.
Cell cycle (Georgetown, Tex.) 2009;8(5):736-41.
-
2009: Pereira L E; Onlamoon N; Wang X; Wang R; Li J; Reimann K A; Villinger F; Pattanapanyasat K; Mori K; Ansari A A
Preliminary in vivo efficacy studies of a recombinant rhesus anti-alpha(4)beta(7) monoclonal antibody.
Cellular immunology 2009;259(2):165-76.
-
2008: Wang Xuening; Patel Rahul; Studzinski George P
hKSR-2, a vitamin D-regulated gene, inhibits apoptosis in arabinocytosine-treated HL60 leukemia cells.
Molecular cancer therapeutics 2008;7(9):2798-806.
-
2008: Jamshidi Farnaz; Zhang Jing; Harrison Jonathan S; Wang Xuening; Studzinski George P
Induction of differentiation of human leukemia cells by combinations of COX inhibitors and 1,25-dihydroxyvitamin D3 involves Raf1 but not Erk 1/2 signaling.
Cell cycle (Georgetown, Tex.) 2008;7(7):917-24.
-
2007: Garay Edward; Donnelly Robert; Wang Xuening; Studzinski George P
Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor.
Journal of cellular physiology 2007;213(3):816-25.
-
2007: Wang Xuening; Wang Tian-Tian; White John H; Studzinski George P
Expression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamin D(3) and is required for optimal cell differentiation.
Experimental cell research 2007;313(14):3034-45.
-
2006: Wang Xuening; Studzinski George P
Raf-1 signaling is required for the later stages of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells but is not mediated by the MEK/ERK module.
Journal of cellular physiology 2006;209(2):253-60.
-
2006: Wang X; Wang T-T; White J H; Studzinski G P
Induction of kinase suppressor of RAS-1(KSR-1) gene by 1, alpha25-dihydroxyvitamin D3 in human leukemia HL60 cells through a vitamin D response element in the 5'-flanking region.
Oncogene 2006;25(53):7078-85.
-
2006: Marcinkowska Ewa; Garay Edward; Gocek Elzbieta; Chrobak Agnieszka; Wang Xuening; Studzinski George P
Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3.
Experimental cell research 2006;312(11):2054-65.
-
2006: Wang Xuening; Studzinski George P
The requirement for and changing composition of the activating protein-1 transcription factor during differentiation of human leukemia HL60 cells induced by 1,25-dihydroxyvitamin D3.
Cancer research 2006;66(8):4402-9.
-
2006: Studzinski G P; Garay E; Patel R; Zhang J; Wang X
Vitamin D receptor signaling of monocytic differentiation in human leukemia cells: role of MAPK pathways in transcription factor activation.
Current topics in medicinal chemistry 2006;6(12):1267-71.
-
2005: Studzinski George P; Wang Xuening; Ji Yan; Wang Qing; Zhang Yingyu; Kutner Andrzej; Harrison Jonathan S
The rationale for deltanoids in therapy for myeloid leukemia: role of KSR-MAPK-C/EBP pathway.
The Journal of steroid biochemistry and molecular biology 2005;97(1-2):47-55.
-
2004: Chen Fei; Wang Qing; Wang Xuening; Studzinski George P
Up-regulation of Egr1 by 1,25-dihydroxyvitamin D3 contributes to increased expression of p35 activator of cyclin-dependent kinase 5 and consequent onset of the terminal phase of HL60 cell differentiation.
Cancer research 2004;64(15):5425-33.
-
2004: Wang Xuening; Studzinski George P
Kinase suppressor of RAS (KSR) amplifies the differentiation signal provided by low concentrations 1,25-dihydroxyvitamin D3.
Journal of cellular physiology 2004;198(3):333-42.
-
2003: Wang Qing; Wang Xuening; Studzinski George P
Jun N-terminal kinase pathway enhances signaling of monocytic differentiation of human leukemia cells induced by 1,25-dihydroxyvitamin D3.
Journal of cellular biochemistry 2003;89(6):1087-101.
-
2002: Ji Yan; Wang Xuening; Donnelly Robert J; Uskokovic Milan R; Studzinski George P
Signaling of monocytic differentiation by a non-hypercalcemic analog of vitamin D3, 1,25(OH)2-5,6 trans-16-ene-vitamin D3, involves nuclear vitamin D receptor (nVDR) and non-nVDR-mediated pathways.
Journal of cellular physiology 2002;191(2):198-207.
-
2001: Danilenko M; Wang X; Studzinski G P
Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents.
Journal of the National Cancer Institute 2001;93(16):1224-33.
-
2001: Wang X; Studzinski G P
Phosphorylation of raf-1 by kinase suppressor of ras is inhibited by "MEK-specific" inhibitors PD 098059 and U0126 in differentiating HL60 cells.
Experimental cell research 2001;268(2):294-300.
-
2001: Wang X; Studzinski G P
Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells.
Journal of cellular biochemistry 2001;82(1):68-77.
-
2001: Dutz J P; Benoit L; Wang X; Demetrick D J; Junker A; de Sa D; Tan R
Lymphocytic vasculitis in X-linked lymphoproliferative disease.
Blood 2001;97(1):95-100.
-
2001: Wang X; Studzinski G P
Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells.
Journal of cellular biochemistry 2001;80(4):471-82.
-
2000: Benoit L; Wang X; Pabst H F; Dutz J; Tan R
Defective NK cell activation in X-linked lymphoproliferative disease.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(7):3549-53.
-
2000: Wang X; Rao J; Studzinski G P
Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D(3)-induced differentiation of human leukemia HL60 cells.
Experimental cell research 2000;258(2):425-37.
-
1997: Wang X; Ponzio N M; Studzinski G P
Long-term exposure of HL60 cells to 1,25-dihydroxyvitamin D3 reduces their tumorigenicity: a model for cancer chemoprevention.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1997;215(4):399-404.
-
1997: Wang X; Studzinski G P
Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c.
Experimental cell research 1997;235(1):210-7.
-
1997: Wang X; Gardner J P; Kheir A; Uskokovic M R; Studzinski G P
Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogues of vitamin D3.
Journal of the National Cancer Institute 1997;89(16):1199-206.
Sign-in to see more